Stocktoria
DEXCOM INC DXCM
DEXCOM INC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.7B | $4.0B | $3.6B | $2.9B | $2.4B | $1.9B | $1.5B | $1.0B | $718.5M | $573.3M |
| Gross profit | $2.8B | $2.4B | $2.3B | $1.9B | $1.7B | $1.3B | $931.5M | $663.9M | $492.1M | $378.4M |
| R&D expense | $599.1M | $552.4M | $505.8M | $484.2M | $517.1M | $359.9M | $273.5M | $199.7M | $185.4M | $156.1M |
| SG&A expense | $1.3B | $1.3B | $1.2B | $1.0B | $810.5M | $618.2M | $515.7M | $432.8M | $349.2M | $286.2M |
| Operating income | $911.8M | $600.0M | $597.7M | $391.2M | $265.8M | $299.5M | $142.3M | -$186.3M | -$42.5M | -$63.9M |
| Interest expense | — | — | $20.3M | $18.6M | $18.8M | $17.7M | $60.3M | $22.7M | $12.8M | $700,000 |
| Income tax | $252.1M | $132.8M | $168.9M | $49.6M | $39.9M | -$251.8M | $3.1M | $600,000 | $1.6M | $700,000 |
| Net income | $836.3M | $576.2M | $541.5M | $341.2M | $216.9M | $549.7M | $101.1M | -$127.1M | -$50.2M | -$65.6M |
| EPS (diluted) | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 | $1.33 | $0.28 | $-0.36 | $-0.14 | — |
| Operating cash flow | $1.4B | $989.5M | $748.5M | $669.5M | $442.5M | $475.6M | $314.5M | $123.2M | $92.0M | $56.2M |
| Free cash flow | $1.1B | $630.7M | $511.9M | $304.7M | $53.3M | $276.6M | $134.5M | $56.1M | $26.0M | $500,000 |
| Cash & equivalents | $917.7M | $606.1M | $566.3M | $642.3M | $1.1B | $817.6M | $446.2M | $1.1B | $441.5M | $94.5M |
| Inventory | $629.1M | $542.6M | $559.6M | $306.7M | $357.3M | $234.7M | $119.8M | $70.7M | $45.2M | $45.4M |
| Total assets | $6.3B | $6.5B | $6.3B | $5.4B | $4.9B | $4.3B | $2.4B | $1.9B | $904.1M | $402.8M |
| Total liabilities | $3.6B | $4.4B | $4.2B | $3.3B | $2.9B | $2.5B | $1.5B | $1.3B | $484.7M | $119.0M |
| Shareholders' equity | $2.7B | $2.1B | $2.1B | $2.1B | $2.0B | $1.8B | $882.6M | $663.3M | $419.4M | $283.8M |
Growth · year-over-year · Revenue CAGR 26.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +15.6% | +11.3% | +24.5% | +18.8% | +27.1% | +30.5% | +43.1% | +43.6% | +25.3% | +42.6% |
| Net income growth | +45.1% | +6.4% | +58.7% | +57.3% | -60.5% | +443.7% | — | — | — | — |
| EPS growth | +47.2% | +9.2% | +58.5% | +54.7% | -60.2% | +383.6% | — | — | — | — |
| Free cash flow growth | +70.8% | +23.2% | +68.0% | +471.7% | -80.7% | +105.7% | +139.8% | +115.8% | +5100.0% | -96.8% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.